JAS IN THE AMERICAS

News From JAS Worldwide - Americas Focus

JAS Americas HQ

6195 Barfield Road

Atlanta GA, 30328

United States

JAS Chile Receives Great Place to Work Award for Second Consecutive Year 

By
October 9, 2024
We're thrilled to announce that JAS Chile has been recognized as a Great Place to Work for the second consecutive year!
We're thrilled to announce that JAS Chile has been recognized as a Great Place to Work for the second consecutive year!

October 2024 – Santiago, Chile – JAS Chile is proud to announce that it has been named a Great Place to Work for the second year in a row. This prestigious recognition highlights the company's commitment to fostering an inclusive, collaborative, and empowering work environment that prioritizes employee well-being and growth. 

The Great Place to Work award is based on employee feedback, recognizing organizations that promote a strong company culture, trust, and engagement. JAS Chile’s continuous efforts to enhance its workplace culture have been instrumental in achieving this honor. The company places a high value on creating an environment where employees feel respected, heard, and motivated to contribute to the company’s success. 

“We are incredibly proud to be recognized again as a Great Place to Work,” said Rodrigo Bustos, Managing Director of JAS Chile. “This achievement is a testament to our team’s dedication and our ongoing commitment to creating a workplace where every employee can thrive. We believe that when our people succeed, our business succeeds.” 

JAS Chile continues to invest in initiatives that promote employee development, diversity, and inclusion, as well as programs focused on mental and physical health. The company strives to maintain a culture that supports work-life balance, innovation, and open communication, making it a rewarding place to work for all team members. 

By receiving this award for the second consecutive year, JAS Chile reaffirms its status as a leading logistics company not only in terms of operational excellence but also as an employer of choice. The company remains committed to nurturing its talented workforce as it continues to grow and expand its global footprint. 

JAS Worldwide to Attend and Sponsor LogiPharma USA 2024

By
September 12, 2024
JAS Worldwide is proud to announce its attendance and sponsorship of LogiPharma USA 2024.
JAS Worldwide is proud to announce its attendance and sponsorship of LogiPharma USA 2024.

JAS Worldwide is proud to announce its attendance and sponsorship of LogiPharma USA 2024, taking place from September 23-25, 2024, in Boston, MA. As a key player in the pharma & healthcare logistics industry, JAS is committed to advancing pharmaceutical supply chain solutions and is excited to engage with industry leaders at this premier event.  


LogiPharma USA is the world's leading event for pharmaceutical supply chain professionals, bringing together industry experts to discuss the latest trends, innovations, and challenges in the field. This year's conference will focus on driving operational excellence, digital transformation, and customer-centric supply chains in the pharmaceutical industry.  

As a sponsor, JAS Worldwide will have a prominent presence at the event, showcasing its innovative logistics solutions designed to meet the unique demands of the pharmaceutical sector. Attendees are invited to visit with JAS Pharma & Healthcare experts at booth 106 to learn about the company's innovative technologies and comprehensive services that ensure the safe, efficient, and compliant movement of pharmaceutical products. 

"LogiPharma USA offers a unique for JAS Worldwide to connect with industry leaders and demonstrate our commitment to advancing pharmaceutical logistics," said Frank Cascante, Global VP Pharma & Healthcare "We look forward to sharing our expertise and exploring new partnerships that drive innovation and improve patient outcomes."  
No items found.

Our Sites use cookies for analytics purposes. For more information about the cookies we use on our Sites or how you can disable them, please see our Cookie Policy.